<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom">
  <channel>
    <title>Europacific Growth Fund Class F-1 — News on 6ix</title>
    <link>https://6ix.com/company/europacific-growth-fund-class-f-1</link>
    <description>Latest news and press releases for Europacific Growth Fund Class F-1 on 6ix.</description>
    <language>en-us</language>
    <lastBuildDate>Wed, 22 Apr 2026 04:00:00 GMT</lastBuildDate>
    <generator>6ix RSS</generator>
    <atom:link href="https://6ix.com/rss/company/europacific-growth-fund-class-f-1" rel="self" type="application/rss+xml" />
    <item>
      <title>ClearPoint Neuro Announces FDA Clearance of the Velocity Alpha(R) MR High Speed Surgical Drill System and First Clinical Use, Further Expanding Our Drug Delivery Ecosystem and Global Footprint</title>
      <link>https://6ix.com/company/europacific-growth-fund-class-f-1/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-25</link>
      <guid isPermaLink="true">https://6ix.com/company/europacific-growth-fund-class-f-1/news/clearpoint-neuro-announces-fda-clearance-of-the-velocity-alphar-mr-high-speed-surgical-drill-system-and-first-clinical-use-further-expanding-our-drug-delivery-ecosystem-and-global-footprint-25</guid>
      <pubDate>Wed, 22 Apr 2026 04:00:00 GMT</pubDate>
      <description>SOLANA BEACH, CA / ACCESS Newswire / April 22, 2026 / ClearPoint Neuro, Inc. (NASDAQ:CLPT) (&quot;Company&quot;), a global device, cell, and gene therapy-enabling</description>
    </item>
  </channel>
</rss>